Analyst Ratings for Cellebrite (CLBT)
CLBT Rating Summary
CLBT Price Target Summary
- Highest: $25.00 (BofA Securities)
- Lowest: $15.00 (Needham)
- Average: $21.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.71 (+69.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$21.71 (+69.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | DA Davidson | Rudy Kessinger | New Coverage | Buy (N/A) |
20.00 (N/A) |
13.18 (12.83) |
-2.66% | Details |
| 4/19/2024 | Lake Street » Updated 2/12/2026 |
Eric Martinuzzi | New Coverage | Buy (N/A) |
21.00 (23.00) |
10.38 (12.83) |
23.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
